Matar o repel·lir?Superfícies antimicrobianes basades en plata

  1. Cristina García-Bonillo 1
  2. Robert Texidó 1
  3. Joan Gilabert-Porres 2
  4. Salvador Borrós 1
  1. 1 Universitat Ramon Llull. Institut Químic de Sarrià (IQS)
  2. 2 Tractivus, SL
Revista:
Revista de la Societat Catalana de Química

ISSN: 2013-9853,  1576-8961

Any de publicació: 2020

Número: 19

Pàgines: 46-55

Tipus: Article

DOI: 10.2436/20.2003.01.116 DIALNET GOOGLE SCHOLAR lock_openAccés obert editor

Altres publicacions en: Revista de la Societat Catalana de Química

Resum

Els dispositius mèdics són essencials per a la prevenció i el tractament d’un gran nombre de malalties. Tanmateix, el seu ús generalitzat pot provocar-ne la colonització bacteriana. Per açò, actualment hi ha un esforç global per desenvolupar tecnologies que dotin els dispositius mèdics de propietats antimicrobianes [1, 2]. Entre aquestes estratègies, es troba la depo- sició de plata sobre les superfícies d’aquests dispositius. Aquesta estratègia, però, obre un debat interessant: què és més efec- tiu, matar els bacteris mitjançant l’alliberament controlat de plata per evitar la infecció, o impedir només que colonitzin el dispositiu mèdic?

Referències bibliogràfiques

  • gilaBert-Porres, J.; martí, s.; calatayud, l.; ramos, v.; rosell, a.; Borrós, S. «Design of a nanostructured active surface against gram-positive and gram-negative bacteria through plasma activation and in situ silver reduction». ACS Appl. Ma- ter. Interfaces [en línia], 8 (1) (2016), p. 64-73. https:// doi.org/10.1021/acsami.5b07115 .
  • yang, z.; Wu, y.; Wang, J.; cao, B.; tang, C. Y. «In situ reduc- tion of silver by polydopamine: a novel antimicrobial modifi- cation of a thin-film composite polyamide membrane». En- viron. Sci. Technol. [en línia], 50 (17) (2016), p. 9543-9550. https://doi.org/10.1021/acs.est.6b01867 .
  • KHan, H. a.; aHmad, a.; meHBooB, R. «Nosocomial infections and their control strategies». Asian Pacific Journal of Tropical Biomedicine [en línia] [Elsevier], 5 (7) (2015), p. 509-514. https://doi.org/10.1016/j.apjtb.2015.05.001
  • desrousseauX, c.; sautou, v.; descamPs, s.; traoré, O. «Modifica- tion of the surfaces of medical devices to prevent microbial ad- hesion and biofilm formation». J. Hosp. Infect. [en línia], 85 (2) (2013), p. 87-93. https://doi.org/10.1016/j.jhin.2013.06.015 .
  • World HealtH organization. The burden of health care- associated infection worldwide [en línia], 2011. http:// www.who.int/infection-prevention/publications/burden _hcai/en/ .
  • BJÖrling, g.; JoHansson, d.; BergstrÖm, l.; streKalovsKy, a.; sáncHez, J.; frostell, c.; Kalman, S. «Evaluation of central venous catheters coated with a noble metal alloy: A randomized clin-ical pilot study of coating durability, performance and tolera- bility». J. Biomed. Mater. Res. - Part B Appl. Biomater. [en lí- nia], 106 (6) (2018), p. 2337-2344. https://doi.org/10.1002/ jbm.b.34041 .
  • tacconelli, e.; smitH, g.; HieKe, K.; lafuma, a.; Bastide, P. «Epi- demiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four Euro- pean countries: Literature- and registry-based estimates». J. Hosp. Infect. [en línia], 72 (2) (2009), p. 97-103. https:// doi.org/10.1016/j.jhin.2008.12.012 .
  • Klevens, r. m.; edWards, J. r.; ricHards, c. l.; Horan, t. c.; gaynes, r. P.; PollocK, d. a.; cardo, D. M. «Estimating health care-associated infections and deaths in U.S. hospitals, 2002». Public Health Rep. [en línia], 122 (2) (2007), p. 160-166. https://doi.org/10.1177/003335490712200205 . Verleyen, P.; ridder, D. de; PoPPel, H. van; Baert, L. «Clinical application of the Bardex IC Foley catheter». Eur. Urol. [en lí- nia], 36 (3) (1999), p. 240-246. https://doi.org/10.1159/ 000068005 .
  • Al-Hazmi, H. «Role of duration of catheterization and length of hospital stay on the rate of catheter-related hospital- acquired urinary tract infections». Res. Reports Urol. [en línia], 7 (2015), p. 41-47. https://doi.org/10.2147/RRU.S75419 .
  • EuroPean centre for disease Prevention and control. «Health- care-associated infections acquired in intensive care units». A: Annual Epidemiological Report for 2017. Estocolm, 2019.
  • Ha, u.-s.; cHo, Y.-H. «Catheter-associated urinary tract infections: New aspects of novel urinary catheters». Int. J. An- timicrob. Agents [en línia], 28 (6) (2006), p. 485-490. https:// doi.org/10.1016/j.ijantimicag.2006.08.020 .
  • riBeiro, s. m.; felício, m. r.; Boas, e. v.; gonçalves, s.; costa, f. f.; samy, r. P.; santos, n. c.; franco, O. L. «New froniers for anti-biofilm drug development». Pharmacol. Ther. [en línia], 160 (2016), p. 133-144. https://doi.org/10.1016/ j.pharmthera.2016.02.006 .
  • Haque, m.; sartelli, m.; mcKimm, J.; BaKar, M. A. «Health care-associated infections: An overview». Infect. Drug Resist. [en línia], 11 (2018), p. 2321-2333. https://doi.org/10.2147/ IDR.S177247 . Salmanov, a.; litus, v.; vdovycHenKo, s.; litus, o.; davtian, l.; uBogov, s.; BisyuK, y.; drozdova, a.; vlasenKo, I. «Healthcare- associated infections in intensive care units». Wiad. Lek., 72 (5 cz 2) (2019), p. 963-969.
  • THomas, c.; stevenson, m.; riley, T. V. «Antibiotics and hospital-acquired clostridium difficile-associated diarrhoea: A systematic review». J. Antimicrob. Chemother. [en línia], 51 (6) (2003), p. 1339-1350. https://doi.org/10.1093/jac/dkg254 .
  • Hagan, e. c.; donnenBerg, m. s.; moBley, H. L. T. «Uropatho- genic Escherichia coli». EcoSal Plus [en línia], 3 (2) (2009), p. 1-39. https://doi.org/10.1128/ecosalplus.8.6.1.3 .
  • Pendleton, J. n.; gorman, s. P.; gilmore, B. F. «Clinical rele- vance of the ESKAPE pathogens». Expert Rev. Anti. Infect. Ther. [en línia], 11 (3) (2013), p. 297-308. https://doi.org/10.1586/ eri.13.12 .
  • flores-mireles, a. l.; WalKer, J. n.; caParon, m.; Hultgren, S. J. «Urinary tract infections: Epidemiology, mechanisms of infec- tion and treatment options». Nat. Rev. Microbiol. [en línia], 13 (5) (2015), p. 269-284. https://doi.org/10.1038/ nrmicro3432 .
  • redacción. «Gasto de la infección nosocomial o cómo me- jorar la calidad: un programa dirigido a clínicos y gestores». EIDON [en línia], 39 (2013), p. 68-75. https://doi.org/ 10.13184/eidon.39.2013.68-75 .
  • daniels, K. r.; lee, g. c.; frei, C. R. «Trends in catheter- associated urinary tract infections among a national cohort of hospitalized adults, 2001-2010». Am. J. Infect. Control [en lí- nia], 42 (1) (2014), p. 17-22. https://doi.org/10.1016/ j.ajic.2013.06.026 .
  • gutman, J.; WalKer, s. l.; freger, v.; HerzBerg, M. «Bacterial attachment and viscoelasticity: Physicochemical and motility effects analyzed using quartz crystal microbalance with dissi- pation (QCM-D)». Environ. Sci. Technol. [en línia], 47 (1) (2013), p. 398-404. https://doi.org/10.1021/es303394w .
  • floyd, K. a.; eBerly, a. r.; HadJifrangisKou, M. «Adhesion of bacteria to surfaces and biofilm formation on medical devices». A: Biofilms and implantable medical devices [en línia]. Elsevier, 2017, p. 47-95. ISBN: 9780081003985. https://doi. org/10.1016/B978-0-08-100382-4.00003-4
  • fernandes, P.; martens, E. «Antibiotics in late clinical de-velopment». Biochem. Pharmacol. [en línia], 133 (2017), p. 152-163. https://doi.org/10.1016/j.bcp.2016.09.025 .
  • PallascH, T. J. «Antibiotic resistance». Dent. Clin. North Am. [en línia], 47 (4) (2003), p. 623-639. https://doi.org/ 10.1016/S0011-8532(03)00039-9 .
  • rHee, K. y.; gardiner, D. F. «Clinical relevance of bacterio-static versus bactericidal activity in the treatment of gram- positive bacterial infections». Clin. Infect. Dis. [en línia], 39 (5) (2004), p. 755-756. https://doi.org/10.1086/422881 .
  • PugacH, J. l.; ditizio, v.; mittelman, m. W.; Bruce, a. W.; dicosmo, f.; KHoury, A. E. «Antibiotic hydrogel coated Foley catheters for prevention of urinary tract infection in a rabbit model». J. Urol. [en línia], 162 (3 I) (1999), p. 883-887. https://doi.org/10.1097/00005392-199909010-00084 .
  • risso, a.; Braidot, e.; sordano, m. c.; vianello, a.; macrì, f.; sKerlavaJ, B.; zanetti, m.; gennaro, r.; Bernardi, P. «BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore». Mol. Cell. Biol. [en línia], 22 (6) (2002), p. 1926-1935. https://doi.org/10.1128/MCB.22.6.1926 .
  • Wang, l.; Hu, c.; sHao, L. «The antimicrobial activity of nanoparticles: Present situation and prospects for the future». Int. J. Nanomedicine [en línia], 12 (2017), p. 1227-1249. https://doi.org/10.2147/IJN.S121956 .
  • cHristie, r. J.; findley, d. J.; dunfee, m.; Hansen, r. d.; olsen, s. c.; grainger, D. W. «Photopolymerized hydrogel carriers for live vaccine ballistic delivery». Vaccine [en línia], 24 (9) (2006), p. 1462-1469. https://doi.org/10.1016/j.vaccine.2005.05.048 .
  • rossmann, f. s.; raceK, t.; WoBser, d.; PucHalKa, J.; raBener, e. m.; reiger, m.; HendricKX, a. P. a.; diedericH, a. K.; Jung, K.; Klein, C. [et al.]. «Phage-mediated dispersal of biofilm and dis- tribution of bacterial virulence genes is induced by quorum sensing». PLoS Pathog. [en línia], 11 (2) (2015), p. 1-17. https://doi.org/10.1371/journal.ppat.1004653 .
  • simões, m.; simões, l. c.; vieira, M. J. «A review of current and emergent biofilm control strategies». LWT - Food Sci. Tech-nol. [en línia], 43 (4) (2010), p. 573-583. https://doi.org/ 10.1016/j.lwt.2009.12.008 .
  • Beloin, c.; renard, s.; gHigo, J. m.; leBeauX, D. «Novel approaches to combat bacterial biofilms». Curr. Opin. Pharma- col. [en línia], 18 (2014), p. 61-68. https://doi.org/10.1016/ j.coph.2014.09.005 .
  • Lemire, J. a.; Harrison, J. J.; turner, R. J. «Antimicrobial ac- tivity of metals: mechanisms, molecular targets and applications». Nat. Rev. Microbiol. [en línia], 11 (6) (2013), p. 371- 384. https://doi.org/10.1038/nrmicro3028 .
  • zou, X.; deng, P.; zHou, c.; Hou, y.; cHen, r.; liang, f.; liao, L. «Preparation of a novel antibacterial chitosan-poly(ethylene glycol) cryogel/silver nanoparticles composites». J. Biomater. Sci. Polym. Ed. [en línia], 28 (13) (2017), p. 1324-1337. https://doi.org/10.1080/09205063.2017.1321346 .
  • diKon, a.; olaH, R. «Silver coated Foley catheters: Initial cost is not the only thing to consider». Am. J. Infect. Control [en línia], 34 (5) (2006), E39-E40. https://doi.org/10.1016/j. ajic.2006.05.204 .
  • Beattie, m.; taylor, J. «Silver alloy vs. uncoated urinary catheters: A systematic review of the literature». J. Clin. Nurs. [en línia], 20 (15-16) (2011), p. 2098-2108. https://doi.org/ 10.1111/j.1365-2702.2010.03561.x .
  • qing, y.; cHeng, l.; li, r.; liu, g.; zHang, y.; tang, X.; Wang, J.; liu, H.; qin, Y. «Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies». Int. J. Nanomedicine [en línia], 13 (2018), p. 3311-3327. https://doi.org/10.2147/ IJN.S165125 .
  • Holt, K. B.; Bard, A. J. «Interaction of silver(I) ions with the respiratory chain of Escherichia coli: an electrochemical and scanning electrochemical microscopy study of the anti- microbial mechanism of micromolar Ag». Biochemistry [en lí- nia], 44 (39) (2005), p. 13214-13223. https://doi.org/ 10.1021/bi0508542 .
  • tian, X.; Jiang, X.; WelcH, c.; croley, t. r.; Wong, t.-y.; cHen, c.; fan, s.; cHong, y.; li, r.; ge, C. [et al.]. «Bactericidal effects of silver nanoparticles on Lactobacilli and the under- lying mechanism». ACS Appl. Mater. Interfaces [en línia], 10 (10) (2018), p. 8443-8450. https://doi.org/10.1021/ acsami.7b17274
  • guPta, a.; matsui, K.; lo, J. f.; silver, S. «Molecular basis for resistance to silver cations in Salmonella». Nat. Med. [en línia], 5 (2) (1999), p. 183-188. https://doi.org/10.1038/5545 .
  • PanácˇeK, a.; KvíteK, l.; sméKalová, m.; vecˇerˇová, r.; Kolárˇ, m.; rÖderová, m.; dycˇKa, f.; ŠeBela, m.; PruceK, r.; tomanec, O. [et al.]. «Bacterial resistance to silver nanoparticles and how to overcome it». Nat. Nanotechnol. [en línia], 13 (2017), p. 1-7. https://doi.org/10.1038/s41565-017-0013-y .
  • liao, s.; zHang, y.; Pan, X.; zHu, f.; Jiang, c.; liu, q.; cHeng, z.; dai, g.; Wu, g.; Wang, L. [et al.]. «Antibacterial activity and mechanism of silver nanoparticles against multidrug- resistant Pseudomonas aeruginosa». Int. J. Nanomedicine [en línia], 14 (2019), p. 1469-1487. https://doi.org/10.2147/ IJN.S191340 .
  • gosHeger, g.; Hardes, J.; aHrens, H.; streitBurger, a.; Buerger, H.; erren, m.; gunsel, a.; KemPer, f. H.; WinKelmann, W.; eiff, C. von. «Silver-coated megaendoprostheses in a rabbit model: An analysis of the infection rate and toxicological side effects». Biomaterials [en línia], 25 (24) (2004), p. 5547-5556. https://doi.org/10.1016/j.biomaterials.2004.01.008 .
  • lee, s. H.; Jun, B. H. «Silver nanoparticles: Synthesis and application for nanomedicine». Int. J. Mol. Sci. [en línia], 20 (4) (2019), p. 219-223. https://doi.org/10.3390/ijms20040865 .
  • garmasHeva, i.; KovalenKo, n.; voycHuK, s.; ostaPcHuK, a.; livins’Ka, o.; olescHenKo, L. «Lactobacillus species mediated synthesis of silver nanoparticles and their antibacterial activ-ity against opportunistic pathogens in vitro». BioImpacts [en línia], 6 (4) (2016), p. 219-223. https://doi.org/10.15171/ bi.2016.29 .
Fuente de los datos: Dialnet